California, United States, August 2024 – Frontage Laboratories Inc. announced today the promotion of Dr. Wentao Zhang to Chief Strategy Officer, continuing his reporting to Dr. Abdul Mutlib, Chief Executive Officer.
Dr. Zhang has been a pivotal member of Frontage’s executive team, successfully leading global restructuring and the expansion of the Drug Discovery and Chemistry business. He joined Frontage Laboratories in 2021 following the acquisition of Quintara Discovery, a niche services organization in California, which he founded in 2012. In his new role, Dr. Zhang will oversee Frontage’s comprehensive end-to-end services in drug discovery, preclinical safety and toxicology, and pharmaceutical development.
“Our Chairman, Dr. Song Li, and I see great potential in Wentao’s leadership to grow and expand Frontage’s business globally. We are confident in his ability to elevate our preclinical and pharmaceutical development services as we work towards becoming a billion-dollar revenue organization by 2028,” said Dr. Abdul Mutlib, CEO.
“I am excited and humbled to take on this new role and sincerely appreciate the trust placed on me by our Chairman, CEO and rest of my colleagues. Since I joined Frontage, I’ve had an incredible opportunity to meet and work with many talented people. Our people are our most valuable assets. I am also amazed by the rapid growth of Frontage and its broad range of services offered. I feel confident that Frontage will continue to grow despite the current headwinds in the global biotech industry. I am looking forward to working with our team members, our customers, and our collaborators” expressed Dr. Zhang.
About Frontage Laboratories, Inc.
Frontage Laboratories, Inc. is a Contract Research Organization (CRO) providing integrated, science-driven product development services across the drug discovery and development process. The company enables pharmaceutical and biotechnology firms to achieve their development goals through a broad range of services, including drug metabolism and pharmacokinetics, analytical testing, formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment, and early phase clinical studies.
Read Also : Imagination in a Disrupted Age: Navigating the Future with Curiosity and Empathy
